Last reviewed · How we verify
Comparison 2: Conservative fluids
Conservative fluid management is a clinical strategy that restricts intravenous fluid administration to minimize fluid overload and associated complications.
Conservative fluid management is a clinical strategy that restricts intravenous fluid administration to minimize fluid overload and associated complications. Used for Perioperative fluid management in major surgery, Sepsis and critical illness fluid resuscitation.
At a glance
| Generic name | Comparison 2: Conservative fluids |
|---|---|
| Also known as | intravenous saline (0.9%) for injection |
| Sponsor | Dr. Damon Scales |
| Modality | Small molecule |
| Therapeutic area | Critical Care / Perioperative Medicine |
| Phase | FDA-approved |
Mechanism of action
Conservative fluid protocols limit the volume and rate of IV fluid delivery during perioperative care or critical illness, aiming to reduce pulmonary edema, tissue edema, and organ dysfunction. This approach contrasts with liberal fluid strategies and is based on evidence that excessive fluid administration can worsen outcomes in certain patient populations, particularly in surgery and sepsis management.
Approved indications
- Perioperative fluid management in major surgery
- Sepsis and critical illness fluid resuscitation
Common side effects
- Acute kidney injury
- Hypotension
- Tissue hypoperfusion
Key clinical trials
- Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP) (PHASE4)
- Implication of Fluid Strategies Upon Hepatic Outcome in Hepatobiliary Surgery (PHASE1, PHASE2)
- Comparison of Balloon Kyphoplasty, Vertebroplasty and Conservative Management in Acute Osteoporotic Vertebral Fractures (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Comparison 2: Conservative fluids CI brief — competitive landscape report
- Comparison 2: Conservative fluids updates RSS · CI watch RSS
- Dr. Damon Scales portfolio CI